WINSTON GRINER: Open Payments
NPI 1922136449 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,133 in 17 payments from 10 companies in 2025. Trend: 2023 $950 · 2024 $1,249 · 2025 $2,133
Food & beverage: $2,133
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $429 |
| Alkermes, Inc. | 2 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $247 |
| E.R. Squibb & Sons, L.L.C. | 2 | $241 |
| Axsome Therapeutics, Inc. | 2 | $240 |
| Teva Pharmaceuticals USA, Inc. | 2 | $234 |
| Braeburn Inc. | 1 | $129 |
| ABBVIE INC. | 1 | $125 |
| Indivior Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
Products named: INVEGA SUSTENNA, CAPLYTA, COBENFY, Auvelity, BRIXADI, VIVITROL, VRAYLAR, SUBLOCADE.
Industry payments across TN — which companies pay providers there.
